2016 Archives
You are viewing archived information from 2016
HB1671     
Measure Title: RELATING TO OPIOID ANTAGONISTS.
Report Title: Opioid Antagonist; Naloxone Hydrochloride; Drug Overdose Prevention; Emergency Response; Medical Immunity; Appropriation
Description: Creates immunity for individuals who prescribe, possess, or administer an opioid antagonist such as naloxone hydrochloride during an opioid-related drug overdose. Authorizes emergency personnel to administer naloxone hydrochloride. Requires medicaid coverage for naloxone hydrochloride. Exempts pharmacists and pharmacies from licensure and permitting requirements, except for drug storage requirements, for storing and distributing opioid antagonists. Makes an appropriation for drug overdose recognition, prevention, and response, including the distribution and administration of naloxone hydrochloride.
Companion:  SB2392
Package: None
Current Referral: HLT, CPC/JUD, FIN
Introducer(s): BELATTI, EVANS, JOHANSON, KOBAYASHI, LOPRESTI, LOWEN, MORIKAWA, SAIKI, WOODSON
Act:

Sort by Date Status Text
1/25/2016HReferred to HLT, CPC/JUD, FIN, referral sheet 1
1/21/2016HIntroduced and Pass First Reading.
1/20/2016HPending introduction.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


HB1671
All Versions of this Measure

Committee Reports
No other committee reports available at this time. You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.

Testimony
No testimony available at this time.

Hearing Notices
No hearings scheduled